Managing gastroesophageal reflux disease – comparative efficacy and outcomes of dexlansoprazole MR
Jeanetta W Frye, David A Peura Division of Gastroenterology and Hepatology, University of Virginia Health Sciences Center, Charlottesville, VA, USA Abstract: The management of gastroesophageal reflux disease (GERD) has been revolutionized with the development of proton pump inhibitors (PPIs). Unfort...
Saved in:
Main Authors: | Frye JW (Author), Peura DA (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2015-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical efficacy of 60-mg dexlansoprazole and 40-mg esomeprazole after 24 weeks for the on-demand treatment of gastroesophageal reflux disease grades A and B: a prospective randomized trial
by: Chiang HH, et al.
Published: (2019) -
Management of gastroesophageal reflux disease in adults
by: Ramin Niknam, et al.
Published: (2015) -
Gastroesophageal Reflux Disease
Published: (2012) -
Endoscopic Management of Gastroesophageal Reflux Disease: Revisited
by: Zaheer Nabi, et al.
Published: (2016) -
Gastroesophageal Reflux Disease Theory and Research
Published: (2019)